Loading
Latest filing published 12 May 2022 for Eupraxia Pharmaceuticals Inc., €116k.
No signal scores available.
All filings by Morgan Frank on record concern Eupraxia Pharmaceuticals Inc. Between 20 April 2022 and 10 May 2022, the trades on record add up to 5 filings.
Every open-market trade on record is a purchase: 1 purchase worth €116k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 12 May 2022 came the latest disclosure, an open-market purchase for €116k in Eupraxia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEDI, the median delay is 13 days. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations